TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Net margin 2023–2025
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) net profit margin by fiscal year — reported net income divided by reported revenue.
-946.2%FY2025 · since FY2023: -1501.8% → -946.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -946.2% | +342.0 pp |
| FY2024 | -1288.3% | +213.5 pp |
| FY2023 | -1501.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNXP financial trends
TNXP RevenueTNXP Net incomeTNXP Gross profitTNXP Gross marginTNXP Operating incomeTNXP Operating marginTNXP Operating cash flowTNXP Free cash flowTNXP Capital expendituresTNXP Return on equityTNXP Stock buybacksTNXP Dividends paidTNXP Total assetsTNXP Total liabilitiesTNXP Shareholders’ equityTNXP overview →